Dr. Andrea Kroeker obtained a Ph.D. in physiology at the University of Manitoba, Canada, in 2015 where she studied proteomic responses of human airway epithelial cells to H1N1 influenza infection. Her thesis defined numerous novel cellular signaling pathways that were activated by influenza infection and could be further investigated as potential antiviral targets. As a postdoctoral fellow, she has spent one year in the Special Pathogens Unit at the Public Health Agency of Canada, testing novel treatments and vaccines for Ebola virus. Dr. Kroeker then moved to the Special Pathogens Unit at the Canadian Food Inspection Agency where she currently works primarily with Rift Valley fever virus (RVFV) to develop diagnostics, animal models, and tests novel vaccines in livestock. For example, recent projects have included identifying the most effective route of inoculation for goat and cattle models of RVFV which are now being utilized for testing multivalent RVFV-poxvirus vaccines.